Apr 13, 2007 by Charly TraversThird Point's PotshotsThe asset management firm's attacks on PDL Biopharma and its CEO have gotten personal.
Jan 25, 2007 by Charly TraversThe Best Drug Stock for 2007 Is ...Last week, we asked you to vote. Now it's time to reveal the winner.
Jan 19, 2007 by Charly TraversThe Best Drug Stock for 2007Help us choose the best drug stock for 2007.
Jul 11, 2006 by Charly TraversAll-Star Stocks: Grand Slam BiotechsThe Fool's biotech specialist picks his favorite lineup.
Apr 13, 2006 by Charly TraversA Foolish Baby Shower: Vanguard 500 IndexAn investing idea so simple, an infant could do it.
Mar 28, 2006 by Charly Travers"60 Minutes" Blew ItThe venerable news show stumbles in its coverage of short selling.
Mar 22, 2006 by Charly TraversStock Madness 2006: The Biotech Dream TeamThe rewards can cancel out the risks, and then some.
Mar 16, 2006 by Charly TraversStock Madness 2006: Health Care and Hem-StitchingThis powerhouse team has long-term potential.
Jan 17, 2006 by Charly TraversFools Want to Know, With ExelixisFool biotech analyst Charly Travers sits down with the company's management team.
Oct 31, 2005 by Charly TraversA Myriad of SharesManagement's predilection for excessive share dilution at this predictive medicine business is troubling for investors.
Sep 29, 2005 by Charly TraversDueling Fools: Baidu.com Bear RebuttalIf you liked Altavista and Lycos, you'll love Baidu.
Sep 13, 2005 by Charly TraversQuality Systems: Vote No!A team of Fools analyzes the divisive proxy battle at this multibagger.
Aug 30, 2005 by Charly TraversA Drug to Make Hearts Happy?Atherogenics has a potential blockbuster in a drug that could reverse the clogging of arteries.
Aug 25, 2005 by Charly TraversFollow the EntrepreneurWant to find a stock about to take off? Charly Travers gives you a technique to put you on the trail.
Aug 23, 2005 by Charly TraversThe Worst Deal I've Ever SeenTwo biotechs are set to merge, but the deal looks like one big blunder.
Aug 16, 2005 by Charly TraversAttack of the NanobodiesWill these tiny antibody fragments disrupt the future of biotechnology?
Aug 9, 2005 by Charly TraversDo Cheaters Really Win?Unethical investors have short-term edges, but it's possible to beat the market without a call from the SEC.
Aug 5, 2005 by Charly TraversNo Surprise Over PDL's UpsideProtein Design Labs' overwhelmingly positive earnings release is good news for shareholders.
